The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion

BMC Cancer
Danielle BoganWael M ElShamy

Abstract

Breast cancer is the most globally diagnosed female cancer, with the triple negative breast cancer (TNBC) being the most aggressive subtype of the disease. In this study we aimed at comparing the effect of BRCA1-IRIS overexpression on the clinico-pathological characteristics in breast cancer patients with TNBC or non-TNBC in the largest comprehensive cancer center in Egypt. To reach this goal, we conducted an observational study at the National Cancer Institute (NCI), Cairo University (Cairo, Egypt). The data on all diagnosed breast cancer patients, between 2009 and 2012, were reviewed. BRCA1-IRIS expression measured using real time RT/PCR in these patients' tumor samples was correlated to tumor characteristics, such as to clinico-pathological features, therapeutic responses, and survival outcomes. 96 patients were enrolled and of these 45% were TNBC, and 55% were of other subtypes (hereafter, non-TNBC). All patients presented with invasive ductal carcinomas. No significant difference was observed for risk factors, such as age and menopausal status between the TNBC and the non-TNBC groups except after BRCA1-IRIS expression was factored in. The majority of the tumors in both groups were ≤5 cm at surgery (p = 0.013). However, in ...Continue Reading

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Aug 30, 2000·Nature·C M PerouD Botstein
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A J van de WouwH F P Hillen
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 30, 2002·Science·Lisa M CoussensLynn M Matrisian
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Jul 5, 2003·Cancer Cell·Yibin KangJoan Massagué
Sep 28, 2004·Nature Cell Biology·Wael M ElShamy, David M Livingston
Aug 2, 2005·Nature Reviews. Cancer·Britta WeigeltLaura J van 't Veer
Jan 24, 2007·Breast Cancer Research : BCR·Lisa K DunnwaldChristopher I Li
Jan 3, 2008·Cancer Cell·Yves HüsemannChristoph A Klein
Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emad RakhaJorge Reis-Filho
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
May 18, 2010·Wiener medizinische Wochenschrift·Rupert BartschGuenther G Steger
Oct 14, 2010·Cancer Research·Kerri L ChockWael M ElShamy
Apr 19, 2012·PloS One·Yoshiko ShimizuWael M ElShamy
May 30, 2012·Pathology, Research and Practice·Amira K El-HawaryKhaled R Zalata
Nov 19, 2013·Archives of Pathology & Laboratory Medicine·Patrick L FitzgibbonsSharon Nofech-Mozes
May 23, 2014·Histopathology·Puay Hoon TanSunil R Lakhani
Aug 19, 2014·Oncogene·B T PaulW M ElShamy
Jan 1, 2013·Hereditary Genetics : Current Research·Kartik AysolaVeena N Rao
Jan 15, 2015·Breast Cancer Research : BCR·Zannel BlanchardWael M ElShamy
Aug 2, 2015·Experimental and Molecular Pathology·Abeer BahnassyAbdel-Rahman N Zekri
Apr 23, 2016·Breast Cancer : Targets and Therapy·Omar FaroukSafaa Abdelhady

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.